EP3429680A1 - Dispositif médical implantable actif de traitement combiné du rythme cardiaque et du rythme respiratoire - Google Patents
Dispositif médical implantable actif de traitement combiné du rythme cardiaque et du rythme respiratoireInfo
- Publication number
- EP3429680A1 EP3429680A1 EP17710572.3A EP17710572A EP3429680A1 EP 3429680 A1 EP3429680 A1 EP 3429680A1 EP 17710572 A EP17710572 A EP 17710572A EP 3429680 A1 EP3429680 A1 EP 3429680A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- microprobe
- neurostimulation
- probe
- implanted
- stimulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/3611—Respiration control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3601—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36135—Control systems using physiological parameters
- A61N1/36139—Control systems using physiological parameters with automatic adjustment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37217—Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/375—Constructional arrangements, e.g. casings
- A61N1/37512—Pacemakers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/375—Constructional arrangements, e.g. casings
- A61N1/3756—Casings with electrodes thereon, e.g. leadless stimulators
Definitions
- Active implantable medical device for combined treatment of heart rhythm and respiratory rhythm
- the invention relates to "active implantable medical devices" as defined by Council of European Communities Directive 90/385 / EEC of 20 June 1990, and more specifically the detection of electrical potentials produced by organs and / or electrical stimulation. of these organs.
- a device for combined stimulation of the myocardium and peripheral nervous system indicated, for example, for patients suffering from cardiac rhythm disorders associated with pathologies such as that known under the name of "sleep apnea syndrome". "(SAS).
- SAS cardiac rhythm disorders associated with pathologies such as that known under the name of "sleep apnea syndrome".
- This condition is a condition that can lead to a number of disorders such as diurnal hypersomnolence, rhythm disorders, hypertension, and aggravate the general condition of patients in heart failure situation.
- central apnea which has a neurological cause and does not result from an obstacle to inspiration, may indeed appear as a consequence of heart failure.
- cardiac pathology and respiratory pathology by stimulation therapy of the peripheral nervous system with application of electrical impulses delivered by a probe having its active part.
- a probe having its active part.
- nerve Therapy hereinafter referred to as “neurostimulation”
- bradycardia pacing therapy or myocardial resynchronization with the application of electrical depolarization pulses from one or more probes having their active part implanted in the ventricular and / or atrial cavities (therapy hereinafter referred to as "cardiostimulation”).
- US 2008/0208282 A1 (US 8,909,341 B2) describes such a device for joint stimulation of the myocardium and the nervous system for the treatment of sleep apnea.
- This device comprises a generator box connected to i) detection / stimulation cardiac probes implanted at the level of the two right and left ventricles, ii) a stimulation probe of the region innervated by the hypoglossal nerve, for the modification of the equilibrium sympathovagal patient by applying low energy electrical neurostimulation pulses delivered in phase with biventricular pacing, and iii)
- FIRE I LLE OF REM PLACEM ENT (RULE 26) a diaphragmatic stimulation probe by application of electrical neurostimulation pulses to the phrenic nerve.
- the diaphragmatic stimulating probe also acts as a probe for collecting nerve potentials produced at the rate of breathing movements, which allows the device to synchronize phrenic nerve stimulation pulses with the patient's natural respiratory cycle.
- This known device is made by using conventional technologies, with a generator housing provided with a connection head receiving the proximal end of each of the four probes, the respective distal ends of which have been previously implanted at the sites. corresponding stimulation. It therefore has the disadvantages of conventional stimulators, namely the volume of the generator, the difficulty to reach the stimulation sites (especially in the coronary venous network for the stimulation of the left ventricle), and the need to provide in the procedure implementation of a step of connecting the four probes to the generator, and a step of testing these probes to verify the compliance of the interaction between each probe and the generator.
- the object of the invention is to propose a new combined treatment device structure of the heart rate and respiratory rate that overcomes this type of limitations of known devices.
- an implantable device for combined treatment of cardiac rhythm and respiratory rhythm of the general type disclosed by the aforementioned US 2008/0208282 A1, that is to say comprising: an autonomous unit intended for implantation subcutaneously, this autonomous unit comprising a sealed body housing electronic circuits and means for supplying electrical power to these electronic circuits, the electronic circuits comprising:
- a heart rate control circuit comprising a cardiac potential detection circuit and a cardiostimulation pulse generator
- a respiratory rate control circuit comprising a nerve potential detection circuit and a neurostimulation pulse generator
- SUBSTITUTE SHEET • a combined control circuit for heart rate control and respiratory rate control circuits
- At least one cardiostimulation probe comprising in a distal active part at least one detection and / or stimulation electrode able to be implanted in or on the myocardium of a patient carrying the device;
- At least one neurostimulation probe comprising in a distal active part at least one detection and / or stimulation electrode able to be implanted on or near a nerve of the patient carrying the device.
- the at least one cardiostimulation probe and at least one neurostimulation probe are microprobes comprising at least one microcable formed of an electrically conductive core cable connected to a pole of said electronic circuits, with an insulation layer surrounding the cable core and comprising at least one selectively stripped zone formed in the insulating layer and intended to form said sensing and / or stimulation electrode, the microprobe diameter being at most 1 French (0.33 mm) in its most distal region comprising said selectively denuded zone;
- said device is an autonomous hybrid capsule integrating in the same assembly said autonomous unit, said at least one cardiostimulation probe and said at least one neurostimulation probe, the hybrid capsule being devoid of an electrical connector between the electronic circuits and the cardiostimulation microsondes. and neurostimulation,
- each of the at least one cardiostimulation probe and at least one neurostimulation probe extending the sealed body of the self-contained unit to one side thereof.
- the at least one cardiostimulation microprobe and / or the at least one neurostimulation microprobe is a multipole microprobe comprising a plurality of said electrodes at its distal active portion;
- said cardiostimulation microprobe (120) is a microprobe of stimulation adapted to be implanted in the coronary venous network (RVC) for the stimulation of a left cavity (LV) of the myocardium of the patient carrying the device;
- said microsonde of neurostimulation is a microprobe capable of being implanted in the left pericardiophrenic vein, the length between the body of the autonomous unit and the most distal electrode of the neurostimulation microprobe being 50 to 60 cm;
- said microsonde of neurostimulation is a microprobe capable of being implanted in one of the branched vessels of the left pericardiophrenic vein, the length between the body of the autonomous unit and the most distal electrode of the neurostimulation microprobe being between 60 and 70 cm;
- the device further comprises a neurodetection microprobe capable of being implanted on or near a nerve of an afferent path of the patient carrying the device, and said microprobe is a microprobe capable of being implanted on or near the neurostimulation microprobe. a nerve of an efferent pathway of the patient carrying the device;
- said microdotection microprobe is advantageously a microprobe capable of being implanted in the right pericardioprenic vein, the length between the body of the autonomous unit and the most distal electrode of the neurodetection microprobe being between 55 and 65 cm;
- the electronic circuits of the autonomous unit furthermore comprise transmitting / receiving means of mutual wireless communication by intracorporeal way with intra-body autonomous leadless capsules able to be implanted in or on the myocardium of the patient, and interfacing means of these transmitter / receiver means with the heart rate control circuit.
- Figure 1 is an overview showing, in implantation situation, the various elements of the device of the invention, used in combination in a system further comprising leadless capsules for stimulating the right cavities of the heart.
- Figure 2 is a schematic view showing, outside the context of implantation, the elements of the system shown in Figure 1.
- Figure 3 is an enlarged view of the hybrid capsule of the device of the invention.
- Figure 4 is a block block diagram showing the various elements of the system of the invention and the interactions between these different elements.
- CRT Cardiac Resynchronization Therapy
- BVP Bi-Ventricular Pacing
- bradycardia pacing involves monitoring the electrical potentials of depolarization of the myocardium, and the controlled delivery of pulses together with both ventricles.
- the invention relates to a device comprising at least one cardiostimulation probe, that is to say capable of being implanted in or on the myocardium of a patient carrying the device.
- it will be an endovascular probe for the detection / stimulation of a left cavity, in particular the left ventricle, via the coronary venous network, which is difficult to access (approach of the coronary sinus, navigation through narrow vessels of the venous network, etc.).
- This particular case is one that makes the most of the advantageous features of the device of the invention, but the invention is equally applicable to a device comprising a stimulation probe of another heart chamber, such as the right ventricle and / or the right atrium, instead and in addition to a probe. stimulation of the left ventricle.
- the invention will be described in the context of a set comprising, in addition to the device of the invention, autonomous stimulation devices of the leadless capsule type, in particular for the stimulation of the right cavities of the heart, but these capsules leadless are not part of the device of the invention as such, and the invention can be implemented either without these capsules, or with other means for stimulating the right cavities.
- FIG. 1 shows the various elements of the device of the invention, in implantation situation in the body of the patient, whose various organs are referenced in the following manner:
- VSCG left and right subclavian veins
- VPCPG left and right pericardiophrenic veins
- NPCPG left and right pericardiophrenic nerves, which are nerves running along the respective pericardiophrenic veins
- RVC coronary venous network
- AD, VD, VG right atrium, right ventricle, left ventricle, D: diaphragm.
- the device 100 of the invention shown in implantation situation Figure 1, is also shown in isolation, schematically, Figure 2.
- This device 100 comprises a hybrid capsule 1 10 implanted in a subcutaneous region of the body of the patient.
- hybrid capsule means a device consisting of:
- this body is provided with a probe directly extending the body of the capsule without a solution of continuity (that is to say without intermediate connector), so as to form a monobloc device and fully autonomous;
- this probe being in addition of the "microprobe” type, that is to say a miniaturized probe of very small diameter (typically at most 1.5 French (0.5 mm), preferably at most 1 French (0, 33 mm)) and devoid of internal lumen, formed of a core cable coated with an insulating layer with, in the distal region, one or more selectively denuded regions forming detection / stimulation electrodes.
- the "microprobe” type that is to say a miniaturized probe of very small diameter (typically at most 1.5 French (0.5 mm), preferably at most 1 French (0, 33 mm)) and devoid of internal lumen, formed of a core cable coated with an insulating layer with, in the distal region, one or more selectively denuded regions forming detection / stimulation electrodes.
- the hybrid capsule 1 10 is associated with at least two probes 120, 130, namely a cardiostimulation probe 120 and a neurostimulation probe 130.
- the probe 120 comprises a plurality of detection / stimulation electrodes 122, four in number in the example illustrated, which can be used independently or independently of each other (monopolar or multipolar configuration as appropriate), for stimulate or to detect.
- the ability to advance or retreat the probe into the catheter used for implantation allows to adjust the position of the electrodes vis-à-vis the target area and based on the results of the electrical test at the time of implantation.
- the probe 130 comprises a plurality of electrodes 132, also four in number in the illustrated example, usable independently or not from each other (monopolar or multipole configuration as appropriate). Note that for a better representation these electrodes have been symbolized in the figures by dots but
- FEUI LLE OF REM PLACEM ENT (RULE 26) that, concretely, they do not introduce any extra thickness of the probe at the place where they are, the probes 120 and 130 being probes of "isodiameter" type ensuring an introduction and a navigation without difficulty in the vessels even the narrowest .
- a third probe 140 which is a neurostimulation and / or neurodetection probe also provided with a plurality of electrodes 142, in the same way as the first probe neurostimulation 130.
- Each of the probes 120, 130 and, if appropriate, the probe 140 is a "microprobe" type probe as described in particular in EP 2 455 131 A1, EP 2 559 453 A1, EP 2 581 107 A1 and EP 2 719. 422 A1 (Sorin CRM SAS).
- the very small diameter of the microcable makes it possible to exploit the entire length of the vein and to canulate veins of very small diameter, not exploited by the usual techniques because of the excessive size of the conventional coronary probes. It thus becomes possible to treat new areas difficult to reach and thus optimally use all the veins present in the basal area, in particular to avoid the risk of phrenic stimulation which generally increases when the probe is too distal.
- the size of the probe body is in fact a factor directly related to the controlled guidance capabilities of the probe in the venous coronary network, to be able to select particular stimulation sites located in certain collateral veins.
- the microprobe is made from at least one "microcable" type cable.
- a microcable comprises an electrically conductive core provided with an insulative coating, with the exception of neatly denuded areas for constituting the sensing / stimulating electrodes. It is preferably provided a succession of several stripped zones, together constituting an array of individual electrodes for multiplying the stimulation points in a target area.
- a plurality of electrically independent microcables are assembled together.
- FIRE I LLE OF REM PLACEM ENT (RULE 26) For example, it appears to be stranded to obtain a microprobe with a plurality of distinctly selectable electrodes (multipolar configuration).
- This configuration offers the possibility of implementing a so-called "electrical repositioning" function of selecting, from among several stimulation points corresponding to several electrodes connected to respective microcables of the probe, that ensuring the best efficiency. This selection can be made both at the time of implantation of the probe and later, by performing at regular intervals tests to verify that the site initially chosen is always optimal, and possibly select another if not.
- the microcable can however comprise only one conductor, so that the stripped regions form electrodes which, from the electrical point of view, are all active and electrically connected in parallel to the same potential (monopolar configuration).
- the intrinsic structure of the microcable is that described in particular in EP 2 455 131 A1 and EP 2 581 107 A1 (Sorin CRM), to which reference may be made for further details. These documents also give indications on the procedure for implanting the microcable in a coronary network.
- the core of the microcable is advantageously a multi-wire structure in which each strand is preferably made of nitinol (NiTi alloy) or MP35N-LT (35% Ni, 35% Co , 20% Cr and 10% Mo), the main advantage of which is their extreme fatigue endurance, with a platinum-iridium or tantalum cladding (for radiopacity and biostability).
- nitinol NiTi alloy
- MP35N-LT 35% Ni, 35% Co , 20% Cr and 10% Mo
- platinum-iridium or tantalum cladding for radiopacity and biostability
- the insulation layer of the order of 25 ⁇ of thickness, is formed on the core, for example by coextrusion or by heating of a heat-shrinkable tube.
- the insulation may be a thin layer of parylene where openings are provided for example by plasma ablation to form the electrode, a polyurethane tube interrupted at the electrode locations, or one or more layers consisting of tubes.
- PET polyethylene terephthalate
- fluoropolymer polymer
- PMMA polymethylmethacrylate
- PEEK polyetheretherketone
- the probes 120, 130, 140 are implanted in the pericardial-phrenic veins, respectively left or right VPCPG or VPCPD, by conventional techniques implementing a guide wire, the access to the veins being made via the left subclavian vein.
- VSCG which is a common access for all microprobes 120, 130 and 140. This access is a usual access, which does not imply a modification of the operating techniques for the practitioner responsible for implementing all the elements of the device.
- the cardiostimulation probe 120 is implanted in the RVC coronary venous network to detect LV cardiac potentials and to possibly stimulate the ventricle. This probe is implanted by conventional techniques, with access by the coronary sinus then progression in the venous network of a catheter implantation and positioning of the active part of the probe, carrying the electrodes 122, to the target zone of chosen stimulation.
- the neurostimulation probe 130 is implanted in the left pericardial-phrenic vein VPCPG in the upper part, near the left pericardial-phrenic nerve NPCPG, for the stimulation of this nerve (which is a motor nerve) and thus the diaphragm D in order to regulate the respiratory rhythm of the patient by stimulation applied to this efferent pathway.
- the probe 140 which acts as a neurodetection probe, is implanted in the right pericardiophrenic vein VPCPD in the upper part, near the right pericardiophrene nerve NPCPD, for the detection on this nerve (which is a sensory nerve) of nerve potentials originating from the diaphragm D, so as to obtain feedback signals (feedback signals) that can be used for the precise regulation of the respiratory rhythm.
- the stimulation of the diaphragm D is a quasi-direct stimulation, operated by means of a longer neurostimulation probe (probe whose distal portion is shown in dashed lines at 130 '), the active portion 132 is introduced into one of the
- FIRE I LLE OF REM PLACEM ENT (RULE 26) branched buckets of the left pericardiophrenic vein VPCPG so that this active part is positioned in the vicinity of the diaphragm D.
- the lengths of the probes 120, 130 and 140 are specifically adapted to the function which they must implement. , taking into account the distance separating the hybrid capsule 110 from the target zone to be stimulated and / or from where the nerve or depolarization electrical potentials of the myocardium will have to be collected.
- the length of the probe 130 is typically between 50 and 60 cm approximately.
- the length of the probe 140 is typically between 55 and 65 cm approximately.
- these dimensions are increased by about 10 cm (ie 60 to 70 cm for a probe 130 'of stimulation of the diaphragm via one of the branched vessels of the left pericardiophrenic vein VPCPG.
- autonomous capsules 200, 300 of leadless type respectively implanted in the atrium. right AD and in the right ventricle VD.
- Capsules of the type called “leadless capsules” are devices in the form of autonomous capsules implantable in a heart chamber (ventricle, atrium or even left arterial heart chamber). They are devoid of any physical connection to an implanted main device (such as a stimulation pulse generator box) or not implanted (external device such as programmer or monitoring device for remote monitoring of the patient) and for this reason are qualified leadless, to distinguish them from the electrodes arranged at the distal end of a conventional lead (lead), traversed throughout its length by one or more electrically connecting conductors
- FLEI LLE OF REM PLACEM ENT (REG 26) the electrode distal to a connector intended to be connected to the housing of a pulse generator.
- the leadless capsules 200 and 300 comprise a body provided at one of its ends with an anchoring member, generally a projecting helicoidal screw axially extending the body of the capsule, and intended to penetrate into the heart tissue by screwing to the site. in the same way as for conventional screw probes.
- EP 2 394 695 A1 (Sorin CRM) describes such a type of leadless screw cap.
- Each of the hybrid capsules 100 or leadless 200, 300, as well as the hybrid capsule 110 comprises electronic control circuits coupled to wireless communication transmitter / receiver means to allow mutual communication between the various capsules 1 10, 200, 300 , and the possible communication of the hybrid capsule 1 10 with an external device such as a programmer or a monitoring device.
- the hybrid capsule 1 10 can thus play a role of master device, or concentrator, in a wireless star network architecture, endocavitary leadless capsules 200 and 300 will be slaves devices.
- the treatment of heart rhythm which is a conventional single-chamber, multi-chamber or resynchronization type treatment, is thus associated with a treatment of central sleep apnea by stimulation of the diaphragm via the pericardiophrenic nerve.
- the neurostimulation treatment operates by:
- FIRE I LLE OF REM PLACEM ENT (RULE 26) detection of the return activity of the diaphragm D via the right pericardial-phrenic nerve NPCPD, the variations of electrical potentials of which are collected by the electrodes 142 of the probe 140 implanted in the right pericardiophrenic vein VPCPD close to this nerve, in the configuration where such a probe 140 is present.
- Figure 3 is an enlarged view of the hybrid capsule 1 10 of the device of the invention.
- This capsule is associated with the probes 120, 130 and 140 by a simplified connection system, permanent, devoid of any electrical connector: the probes 120, 130, 140 extend the body of the capsule 1 10 without a solution of continuity because of the absence of connector, with an intermediate transition region 150 providing a gradual gradient of stiffness between the rigid end of the body and the flexible portion of the microworlds.
- the dimensions of the hybrid capsule 1 10 are for example of the order of 10 x 30 x 10 mm.
- This capsule incorporates a low power electronic architecture, typically 5 to 8 ⁇ ⁇ ⁇ , powered by a battery or alternatively a harvester system energy recovery.
- the electronic circuit of the hybrid capsule also integrates one or more servo sensors, for example a 3D accelerometer and a thermistor for measuring body temperature (in a configuration where the body of the hybrid capsule 1 10 is implanted in the -cutané).
- Figure 4 is a block block diagram showing the different elements of the system of the invention and the interactions between these different elements.
- the hybrid capsule 1 10 comprises a circuit 1 12 for controlling the cardiac rhythm, connected to the cardiostimulation probe 120 implanted in the left ventricle, and comprising wireless communication means with the lead capsules 200 and 300 respectively implanted in the atrium. right and in the right ventricle.
- the hybrid capsule 1 10 also comprises a circuit 1 14 for controlling the respiratory rhythm connected to the cardiostimulation probes 130, 140 implanted in the pericardiophrenic veins respectively left and right.
- the circuits 1 12 and 1 14 cooperate with a circuit 1 16 for controlling the device and simultaneous control of the respiratory rate and heart rate, respectively controlled by the circuits 1 14 and 1 12.
- an interface 18 for communicating with an external device 400 which may be in particular a programmer of a practitioner, the communication then serving to interrogate the implanted assembly, read data stored in memory, modify it. some settings, etc.
- the external equipment 400 may also be a home monitoring device, that is to say an external device for home monitoring of the patient's condition, possibly with the possibility of transmitting the information to a remote, hospital or other site. .
- the Smartview Remote Monitoring System from Sorin CRM is an example of such an external device.
- the communication between the hybrid capsule 1 0 and the leadless capsules 200 and 300 is an intracorporeal communication type HBC (Human Body Communication, communicating intracorporeally), implementing for example a communication technique by means of pulses transmitted via the interstitial tissues of the patient's body, these pulses being generated, transmitted, collected and detected by appropriate circuits for example such as those described in EP 2 441 491 A1 (Sorin CRM) and EP 2 486 953 A1 (Sorin CRM).
- the communication between the hybrid capsule 1 10 and the external device 400 is an RF telemetry communication for example in the MICS, MEDS, ISM bands or else using the Bluetooth protocol.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1652297 | 2016-03-18 | ||
PCT/EP2017/056419 WO2017158174A1 (fr) | 2016-03-18 | 2017-03-17 | Dispositif médical implantable actif de traitement combiné du rythme cardiaque et du rythme respiratoire |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3429680A1 true EP3429680A1 (fr) | 2019-01-23 |
Family
ID=56148444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17710572.3A Withdrawn EP3429680A1 (fr) | 2016-03-18 | 2017-03-17 | Dispositif médical implantable actif de traitement combiné du rythme cardiaque et du rythme respiratoire |
Country Status (3)
Country | Link |
---|---|
US (1) | US20190070411A1 (fr) |
EP (1) | EP3429680A1 (fr) |
WO (1) | WO2017158174A1 (fr) |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6132384A (en) * | 1996-06-26 | 2000-10-17 | Medtronic, Inc. | Sensor, method of sensor implant and system for treatment of respiratory disorders |
US7155278B2 (en) * | 2003-04-21 | 2006-12-26 | Medtronic, Inc. | Neurostimulation to treat effects of sleep apnea |
US20060058852A1 (en) * | 2004-09-10 | 2006-03-16 | Steve Koh | Multi-variable feedback control of stimulation for inspiratory facilitation |
US20130197944A1 (en) * | 2004-11-02 | 2013-08-01 | Medtronic, Inc. | Techniques for Data Reporting in an Implantable Medical Device |
US8024029B2 (en) * | 2004-11-02 | 2011-09-20 | Medtronic, Inc. | Techniques for user-activated data retention in an implantable medical device |
WO2006066099A1 (fr) * | 2004-12-17 | 2006-06-22 | Medtronic, Inc. | Systeme et methode pour reguler une therapie a declenchement cardio-pulmonaire, administree au cerveau |
US7467012B1 (en) * | 2005-06-24 | 2008-12-16 | Pacesetter, Inc. | Respiration parameters controlled by heart rate |
US8103341B2 (en) * | 2006-08-25 | 2012-01-24 | Cardiac Pacemakers, Inc. | System for abating neural stimulation side effects |
US7676268B2 (en) * | 2006-11-30 | 2010-03-09 | Medtronic, Inc. | Medical methods and systems incorporating wireless monitoring |
US8909341B2 (en) * | 2007-01-22 | 2014-12-09 | Respicardia, Inc. | Device and method for the treatment of breathing disorders and cardiac disorders |
EP2394695B1 (fr) | 2010-06-14 | 2012-09-26 | Sorin CRM SAS | Capsule intracardiaque autonome et son accessoire d'implantation |
EP2441491B1 (fr) | 2010-10-18 | 2013-01-09 | Sorin CRM SAS | Implant médical actif autonome, avec un circuit de réveil de l'alimentation sur réception d'impulsions transmises via les tissus interstitiels du corps |
EP2455131B1 (fr) | 2010-11-19 | 2013-01-23 | Sorin CRM SAS | Sonde de stimulation d'une cavité gauche du coeur, implantable dans le réseau coronarien |
EP2486953B1 (fr) | 2011-02-09 | 2016-06-01 | Sorin CRM SAS | Procédé de quantification de la désynchronisation entre les horloges de deux implants actifs de type HBC |
EP2559453B1 (fr) | 2011-08-18 | 2014-07-16 | Sorin CRM SAS | Sonde de stimulation multizone d'une cavité gauche du coeur, implantable dans le réseau coronarien |
EP4043065A1 (fr) | 2011-10-14 | 2022-08-17 | Sorin CRM SAS | Microsonde de détection/stimulation, implantable dans des réseaux veineux, artériels ou lymphatiques |
EP2719422B1 (fr) * | 2012-10-12 | 2015-02-18 | Sorin CRM SAS | Microsonde multipolaire de détection/stimulation implantable |
FR3022760A1 (fr) | 2014-06-25 | 2016-01-01 | Sorin Crm Sas | Ensemble hybride formant dispositif medical implantable actif |
US10058708B2 (en) * | 2015-06-30 | 2018-08-28 | Cardiac Pacemakers, Inc. | Heart failure event detection using minimum heart rate |
-
2017
- 2017-03-17 WO PCT/EP2017/056419 patent/WO2017158174A1/fr active Application Filing
- 2017-03-17 EP EP17710572.3A patent/EP3429680A1/fr not_active Withdrawn
- 2017-03-17 US US16/084,939 patent/US20190070411A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2017158174A1 (fr) | 2017-09-21 |
US20190070411A1 (en) | 2019-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11938016B2 (en) | Endovascular device for sensing and or stimulating tissue | |
US10143844B2 (en) | Nerve stimulation systems via endovascular leads | |
EP2959828B1 (fr) | Ensemble hybride formant dispositif médical implantable actif | |
JP5224579B2 (ja) | 能動埋め込み型医用装置用多重化電極の可制御切り替え回路 | |
US7412289B2 (en) | Multi-electrode lead | |
JP5043189B2 (ja) | ナノ構造を含む医療機器 | |
US6792309B1 (en) | Multi-sensor system for controlling an implantable heart stimulator | |
JP5043190B2 (ja) | 医療電極のコーティング方法、医療電気機器、および医療電気リード線 | |
JP5480871B2 (ja) | 冠状動脈系に植込みされる左心腔のペーシング用リード | |
US9393406B2 (en) | Pacing lead in an extended area of a heart cavity, implantable by over the wire technique in the deep coronary network | |
EP2082684B1 (fr) | Dispositif médical implantable actif comprenant des moyens de communication bidirectionnelle entre en générateur et des capteurs ou actionneurs situés en extrémité de sonde | |
FR2869546A1 (fr) | Controle de l'activite cardiaque d'un stimulateur electrique de l'appareil digestif | |
JP2009521276A (ja) | 植え込み型集積回路 | |
EP1614444A1 (fr) | Stimulateur cardiaque multi-sites à réseau d'électrodes asservies | |
EP2926863A1 (fr) | Utilisation d'un générateur cardiaque implantable de stimulation, défibrillation et/ou resynchronisation du myocarde comme générateur VNS de stimulation du nerf vague | |
WO2017158174A1 (fr) | Dispositif médical implantable actif de traitement combiné du rythme cardiaque et du rythme respiratoire | |
EP2581108B1 (fr) | Module de commutation contrôlée de sonde multiélectrode pour un dispositif médical implantable actif | |
EP3069755B1 (fr) | Dispositif médical implantable actif comprenant une capsule dépourvue de connecteur, reliée de façon permanente à une microsonde | |
WO2020224896A1 (fr) | Conducteur pour un dispositif de stimulateur cardiaque configuré pour fournir une stimulation intra-cardiaque au niveau du faisceau de his | |
US20240099825A1 (en) | Endovascular device for sensing and or stimulating tissue | |
FR2903912A1 (fr) | Stimulateur cardiaque multi-sites a reseau de capteurs et d'actionneurs asservis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20181011 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20220511 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Effective date: 20220623 |